Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on April 22, 2025
Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025
GlobeNewswire
·
April 22, 2025
BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life- …
Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery
GlobeNewswire
·
April 22, 2025
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to …
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
GlobeNewswire
·
April 22, 2025
Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash …
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System
GlobeNewswire
·
April 22, 2025
Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American Spanish-speaking markets Latin American drug screening market projected to reach USD 1.1 billion by 2030 Expansion is …
The Best Natural Testosterone Booster Supplements For Men:~ Honest Customer Reviews 2025
GlobeNewswire
·
April 22, 2025
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Low testosterone levels can cause many problems in men, such as less muscle, less energy, less libido and low mood. You may want to find a solution, but you don’t know which products are good and which are bad. …
BlueGenes Partners with Level Care to Revolutionize Medication Management for Union Members
GlobeNewswire
·
April 22, 2025
SCOTTSDALE, Ariz., April 22, 2025 (GLOBE NEWSWIRE) -- BlueGenes, a pioneering technology company specializing in permission medicine, today announced a strategic partnership with Level Care, the healthcare division of the carpenters union. This …
Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million Americans
GlobeNewswire
·
April 22, 2025
BRIDGEWATER, N.J. and NETANYA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- Theranica, a prescribed neuromodulation therapeutics company, today announced that that its FDA-cleared, non-drug, prescribed migraine treatment, the Nerivio® REN wearable, is now …
SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.
GlobeNewswire
·
April 22, 2025
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through …
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 22, 2025
CORAL GABLES, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
March Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of MB-105, First-in-Class CD5 CAR-T Cell Therapy for T-Cell Lymphoma
GlobeNewswire
·
April 22, 2025
Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseases HOUSTON, April 22, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an emerging clinical stage biotechnology company …
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
GlobeNewswire
·
April 22, 2025
Daxor Brings Advanced Blood Volume Analysis Solutions to Elite Heart and Lung Transplantation Forum Oak Ridge, TN, April 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, will attend the …
InnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025
GlobeNewswire
·
April 22, 2025
DENVER, April 22, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All- …
MBX Biosciences to Participate in Citizens and RBC May Investor Conferences
GlobeNewswire
·
April 22, 2025
CARMEL, Ind., April 22, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids
GlobeNewswire
·
April 22, 2025
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.’s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC …
FluidForm Bio™ Strengthens IP Portfolio with Newly Issued Patent on Key Aspects of its Proprietary FRESH™ Platform
GlobeNewswire
·
April 22, 2025
WALTHAM, Mass., April 22, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,215,202 B2, …
Cellphire Therapeutics Announces CRYPTICS Phase 2/3 Clinical Study Stopped Early for Efficacy Following Pre-Planned Interim Analysis by Independent Data Monitoring Committee (IDMC)
GlobeNewswire
·
April 22, 2025
CRYPTICS study met the primary efficacy endpoint to demonstrate statistical non-inferiority of the cryopreserved CLPH-511 platelet product to the standard of care room temperature control platelet product (RTP) with a one-sided significance level less than …
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
GlobeNewswire
·
April 22, 2025
SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, is pleased to invite investors to a webinar …
Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value
GlobeNewswire
·
April 22, 2025
Strategic diversification into power infrastructure and cryptocurrencies supports long-term biopharma innovation PROVIDENCE, R.I., April 22, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on pioneering …
Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025
GlobeNewswire
·
April 22, 2025
GAITHERSBURG, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 7, 2025, at 5:00 pm eastern time to discuss the financial results for the first quarter of 2025. Participants can …
Best Female Libido Boosters 2025 and Sexual Enhancement Pills for Women - By Oh Yes
GlobeNewswire
·
April 22, 2025
Rhyl, Wales, April 22, 2025 (GLOBE NEWSWIRE) -- A healthy sex life plays an important role in a woman's relationships, mental health, and confidence. However, nearly 1 in 3 women have sexual problems that can erode intimacy such as low libido, vaginal …